deltatrials
Terminated OBSERVATIONAL NCT06506045

Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device

Measurements of Flow in Functional and Non-Functional Cerebrospinal Fluid Shunts With a Second-Generation Wireless Thermal Anisotropy Measurement Device

Sponsor: Rhaeos, Inc.

Conditions Hydrocephalus
Interventions FlowSense
Updated 6 times since 2024 Last updated: May 12, 2025 Started: Jul 27, 2024 Primary completion: Jul 27, 2024 Completion: Jul 27, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Enrollment

Other terminated trials from Rhaeos, Inc.

More terminations from Rhaeos, Inc.

Listed as NCT06506045, this observational or N/A phase trial focuses on Hydrocephalus and remains terminated or withdrawn. Sponsored by Rhaeos, Inc., it has been updated 6 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Feb 2025 · 4 months · monthly snapshotRecruiting~Feb 2025 – ~Apr 2025 · 59 days · monthly snapshotRecruiting~Apr 2025 – ~Jun 2025 · 2 months · monthly snapshotSuspended~Jun 2025 – present · 14 months · monthly snapshotTerminated

Change History

6 versions recorded
  1. Jun 2025 — Present [monthly]

    Terminated

    Status: SuspendedTerminated

  2. Apr 2025 — Jun 2025 [monthly]

    Suspended

    Status: RecruitingSuspended

  3. Feb 2025 — Apr 2025 [monthly]

    Recruiting

  4. Oct 2024 — Feb 2025 [monthly]

    Recruiting

  5. Sep 2024 — Oct 2024 [monthly]

    Recruiting

Show 1 earlier version
  1. Aug 2024 — Sep 2024 [monthly]

    Recruiting

    First recorded

Jul 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Rhaeos, Inc.
Data source: Rhaeos, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .